An Update on EBV and HTLV-1 Induced Cutaneous Manifestations. A Review of the Ibero-American Society of Dermatopathology (SILADEPA). CME Part II

by | Sep 2, 2022 | Publications

J Am Acad Dermatol. 2022 Aug 29:S0190-9622(22)02609-3. doi: 10.1016/j.jaad.2022.07.063. Online ahead of print.


The Epstein Barr virus (EBV) is a DNA virus that infects 90% of the human population, is responsible for certain cutaneous lymphomas (extranodal NK/T-cell lymhoma, hydroa vacciniforme lymphoproliferative disorder, lymphomatoid granulomatosis, others), and can be associated with a variety of cutaneous manifestations (e.g. infectious mononucleosis, severe mosquito bite allergy, chronic active EBV disease, Gianotti Crosti syndrome). EBV-related skin disorders are frequent in certain populations (South and Cental America, Africa, Asia, and Oceania) and can be diagnostically challenging. The human T-lymphotropic virus type-1 (HTLV-1) is a retrovirus which is known to be associated with adult T-cell leukemia/lymphoma, neurologic disorders, but also cutaneous non-neoplastic manifestations (infective dermatitis, infections, and infestations). We performed an updated revision of the clinical dermatologic and histopathologic findings associated with the cutaneous non-neoplastic and preneoplastic disorders occurring in association with the EBV and HTLV-1 virus.

PMID:36049582 | DOI:10.1016/j.jaad.2022.07.063

Other publications you may be interested in…

HTLV-1 Disease

HTLV-1 Disease

HTLV-1 Disease Abstract The years 2020 and 2021 will remain memorable years for many reasons [...]. Click here to...

read more